MALIGNANCY

This study looks at a rare, serious disease called KSHV-associated multicentric Castleman's disease (MCD), which is caused by a virus and often leads to death within two years. Researchers are testing several experimental drug combinations to control the disease and learning how …

This study looks at whether support from a community health worker can help African American patients with advanced cancer feel better and plan their care. About 160 patients will either get standard care or extra help from a health worker. The goal is to see if this support impr…

This study compares different outreach methods to see which works best for getting African Americans to join early phase cancer treatment trials. About 134 patients and their doctors will take part. The goal is to find ways to make cancer research more inclusive.

This study was designed to track immune system recovery and test a pneumococcal vaccine (PCV-21) in people receiving CAR-T therapy for blood cancers or solid tumors. Participants would have had regular clinic visits and blood tests for up to 24 months. However, the study was with…

This study collects medical information and biological samples from 32 cancer patients starting or restarting immunotherapy. The goal is to better understand why some patients develop immune-related side effects and how to manage them. Researchers hope this knowledge will improve…

This study was designed to test a new imaging agent called 68Ga-FAPI-46 in people with solid tumors. The goal was to see if a PET/CT scan using this agent could predict how well a patient's tumor would respond to antibody-based therapy. The study was withdrawn before enrolling an…